| Document |
Document Title |
|
JP4391164B2 |
To provide a chemical reaction method for taking an organic compound, especially a hydrocarbon, into the inner space of a cage-like complex, irradiating the product with light to excite the cage-like complex, thereby subjecting the organ...
|
|
JP4386197B2 |
A noble alicyclic unsaturated compound represented by the general formula (1): wherein at least one of R1 and R2 is a fluorine atom or a fluorinated alkyl group; a polymer formed by the polymerization of a polymer precursor comprising th...
|
|
JP4386730B2 |
A component corresponding to D-chiro-inositol obtained from urine of humans or the like is employed as a management sample in detecting D-chiro-inositol in human urine. In particular, a D-chiro-inositol composition containing at least th...
|
|
JP4383810B2 |
There is disclosed a fluorine-containing polymerizable cyclic olefin compound that has one or more partial structures represented by the following general formula (1) or (2). There can be provided a novel fluorine-containing polymerizabl...
|
|
JP4386154B2 |
|
|
JPWO2008007594A1 |
To provide a novel polymerizable fluorocompound having a highly fluorinated norbornane structure, and a polymer obtained from the compound. Further, their production processes and a novel intermediate useful for the processes. A novel co...
|
|
JP4380488B2 |
|
|
JP4378595B2 |
|
|
JP4372843B2 |
The present invention provides illudin analogs of general formula (I) where R1 is (CH2)n -X-Y or H; n is 0 to 4; X is O or S or N or absent; and Y is an optionally substituted (C1 - C8)alkyl, (C6-C10)aryl, (C6-C10)aryl(C1-C4)alkyl or cyc...
|
|
JP4370898B2 |
|
|
JP4364783B2 |
|
|
JP4360067B2 |
|
|
JP2009256306A |
To provide an adamantane derivative having a polymerizable unsaturated group, on making it a polymer, imparting high flexibility and excellent organic solvent solubility, and also imparting useful properties to a resin for photoresist, s...
|
|
JP4357114B2 |
Vitamin D derivatives having general formula (1) which are hydroxylated at the 24-position and considered as one of metabolites of physiologically active vitamin D derivatives substituted at the 2 beta -position wherein R1, R2, R3 and R4...
|
|
JP4355864B2 |
|
|
JP4354585B2 |
|
|
JP4349227B2 |
|
|
JP4347906B2 |
PCT No. PCT/GB96/01208 Sec. 371 Date Nov. 21, 1997 Sec. 102(e) Date Nov. 21, 1997 PCT Filed May 20, 1996 PCT Pub. No. WO96/37628 PCT Pub. Date Nov. 28, 1996A process for preparing a compound of Formula (3) in which R2 is -H; which compri...
|
|
JP4342156B2 |
To provide a method for simply and efficiently hydrogenating the aromatic ring of an aromatic compound. This method for hydrogenating the aromatic ring of the aromatic compound with hydrogen gas is characterized by using water and a supe...
|
|
JP2009227653A |
To provide a method which can oxidize a cycloalkane with a good conversion to produce a cycloalkanol and/or a cycloalkanone with a good selectivity.The method for producing the cycloalkanol and/or the cycloalkanone comprises oxidizing a ...
|
|
JP4339691B2 |
The composition 3-alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and 3,3'-dialkylated- 5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols are disclosed, as well as various processes for making them, all involving the alkylation of ...
|
|
JP4340817B2 |
|
|
JP4337958B2 |
To detoxicate the catalyst in the reaction system including a platinum group catalyst supported by a carbon carrier and aromatic chlorine compound by carrying out the dechlorination reaction of aromatic chlorine compounds in the presence...
|
|
JP4332698B2 |
To provide a menthol derivative obtained by converting menthol with a fungus, Rhizoctonia solani, a method for producing the same and an antibacterial agent or a sterilizer containing the derivative as an active ingredient. This menthol ...
|
|
JP4324569B2 |
|
|
JP2009529502A |
The invention provides formulations, dosage forms, and treatments comprising cyclohexane polyalcohol compounds that provide beneficial pharmacokinetic profiles in the treatment of a disorder and/or disease including a disorder in protein...
|
|
JP2009529419A |
Catalysts which are prepared by reducing catalyst precursors which comprise a) cobalt and b) one or more elements of the alkali metal group, of the alkaline earth metal group, of the group consisting of the rare earths or zinc or mixture...
|
|
JP2009529569A |
Process for stereoselective hydrogenation by reacting racemic aldehydes or ketones having a stereogenic carbon atom in the position relative to the C(O) group and containing the structural element -(O)C-C-CH- by means of hydrogen in the ...
|
|
JP4316306B2 |
|
|
JP2009529056A |
A method of accelerating the hydrogenation of organic compounds is provided. The method includes positioning an microwave transparent reaction vessel containing at least one reactant suitable for hydrogenation in a microwave cavity, purg...
|
|
JP4312183B2 |
The present invention relates to analogues of vitamin D, which lack the combined presence of the trans-fused six-membered C-ring and of five-membered D-ring, but still possess a central part consisting of a substituted chain of five atom...
|
|
JP4310432B2 |
To provide a new reaction method for carrying out the dehydration reaction or hydration reaction of an organic compound using supercritical water or subcritical water containing carbon dioxide as a reaction medium. The invention relates ...
|
|
JP4303453B2 |
|
|
JP2009525980A |
Compounds of formula IA or IB are provided where X1, X2 and X3 are independently selected from H or hydroxy protecting groups and R1 is selected from straight or branched chain alkyl groups having from 1 to 8 carbon atoms; straight or br...
|
|
JP2009149671A |
To provide a derivative of 5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthol produced by alkylating the 5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthol.The derivative is a 3-alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthol and a 3,3'-di...
|
|
JP4290889B2 |
The present invention relates to a prolactin lowering drug containing at least one bicyclic diterpene of the labdane or clerodane type:wherein R1=H, C1 to C3 alkyl or C1 to C3 acyl.
|
|
JP4294173B2 |
|
|
JP4292712B2 |
A method of efficiently removing the protective group from a protected hydroxyl or amino group with an allyl derivative by one step reaction under neutral conditions. A protected hydroxyl or amino group is converted into a free hydroxyl ...
|
|
JP4288348B2 |
|
|
JP4286486B2 |
|
|
JP2009136807A |
To provide a novel dinuclear metal complex in the reaction process accompanying the oxidation of a substrate (oxygenation as a typical reaction), a high performance oxidation catalyst comprising the metal complex as an active constituent...
|
|
JP4279092B2 |
|
|
JP4276886B2 |
|
|
JP2009120570A |
To provide a new athene-based compound precursor efficiently producing a highly regular electroconductive thin film according to a simple method.The carbonyl-bridged athene-based compound is represented by general formula (1) {wherein, Z...
|
|
JP4267702B2 |
The present invention provides compounds of formula I and methods for their synthesis: (wherein R' and R1 are independently (C1-C4) alkyl, R2 is OH and R3 is methyl).
|
|
JP2009108073A |
To provide a method producing d,l-menthol, using a reprocessable catalyst.In this continuous production method of d,l-menthol, catalytic hydrogenation using hydrogen of a compound which has a p-menthane carbon skeleton containing at leas...
|
|
JP2009102244A |
To provide a method for producing a 3-methyl-cyclopentadecane.A 9-methyl-1,16-heptadecadiene represented by the general formula [I] (wherein X1 and X2 are each CH-OH, CH-OAc (Ac is an acetyl group) or C=O) is reacted in the presence of a...
|
|
JPWO2007063974A1 |
To provide a method for hydrogenating an aromatic ring compound that progresses under relatively mild conditions, which can be carried out even in a small-scale facility, and which has a small burden on the environment. An aromatic ring ...
|
|
JP2009084287A |
To provide a method for manufacturing d,1-menthol from d-menthol.In this manufacturing method of d,1-menthol, catalytic dislocation of an optically active d-menthol is carried out, in the presence of hydrogen, under pressure of 50-350 ba...
|
|
JP4257494B2 |
|
